On September 3.

All rights reserved.. AFP examines latest HIV vaccine findings Agence France-Presse examines how two recent studies have boosted morale among HIV vaccine researchers who’ve struggled for years to develop a viable vaccine to protect people from the virus. On September 3, researchers in the United States discovered two powerful antibodies – – the frontline troops in the disease fighting capability – – that expose what may prove to be a viral Achilles’ heel, the news service writes. It’s a start the road to a vaccine, whereas, before, we didn’t even know where in fact the road was. There’s lots of excitement, Seth Berkley, mind of the International Helps Vaccine Initiative , said.About Actavis Actavis plc , headquartered in Dublin, Ireland, is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing top quality inexpensive generic and innovative branded pharmaceutical products for patients around the global world. Actavis markets a wide portfolio of branded and generic pharmaceuticals and evolves innovative medications for patients suffering from illnesses principally in the central nervous system, gastroenterology, women's health, urology, cardiovascular, respiratory and anti-infective therapeutic categories.